Where does Coviden LP rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Coviden LP ranks #12,394 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Coviden LP hold?

Coviden LP holds 24 US utility patents granted between 2016 and 2025, spanning 14 technology areas.

What is Coviden LP's Innovation Score?

Coviden LP has an Innovation Score of 42.2 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Coviden LP focus on?

Coviden LP's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 21 patents, ranking #851 of 7,127 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Coviden LP's patent grant rate increasing or decreasing?

Coviden LP's recent grant velocity is -31% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Coviden LP's patents?

Coviden LP's patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Coviden LP patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Coviden LP

USPTO PatentsView assignee record - 24 granted patents across 14 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Coviden ranks #12,394 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 14 technology areas.

#12,394
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.2/100): 17.3
avg claims per patent: -31%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12394 · US Corporation #12,394 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 24 grants
UPPER-Q #12,394/49,997
PHOTO-FINISH Classic Auto Air…
CPC-FOCUS A61B · 14 areas
INNOV-PAR 42.2/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -31% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Classic Auto Air Manufacturing LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Coviden’s 42.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (26%) Velocity 7.5 pts (18%) Breadth 13.2 pts (31%) Claim depth 10.4 pts (25%)

Qualcomm Incorporated · highest

85
Coviden · this assignee

42
3D Lighting… · lowest

7

What this shows Coviden's Innovation Score is 42.2/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Coviden?

Each dot is one of Coviden’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Coviden’s own 17.3 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Coviden vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Coviden's grants concentrate

Coviden LP is a focused PatentsView assignee: 14 CPC subclasses with 87.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2016. By volume, Coviden sits between Classic Auto Air Manufacturing LP and D-Link Corporation.

Coviden's three-year grant acceleration

Coviden LP shows 9 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Classic Auto Air…

24
Comcast Cable Hol…

24
Cortec

24
for National Rese…

24
Cumberland Pharma…

24
Cyclerion Therape…

24
Cyral

24
D-link

24
Coviden ◀

24

What this shows Coviden holds 24 patents at rank #12,397, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Coviden

By rank, the assignees closest to #12,397 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Coviden's primary technology class.

Coviden's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Coviden LP patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	8.3%
2017	3	12.5%
2019	8	33.3%
2023	5	20.8%
2024	4	16.7%
2025partial year	2	8.3%

Which technologies does Coviden LP patent most?

A61B - DIAGNOSIS; SURGERY; Identification 21

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

G06T - Image Data Processing OR Generation, IN General 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

G06F - Electric Digital Data Processing 2

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

H01Q - Antennas, i.e. Radio Aerials 1

G02B - Optical Elements, Systems OR Apparatus 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Coviden LP's patent record in context - here's where to go next.

Coviden LP's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 87.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #12,394 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Coviden LP against Classic Auto Air Manufacturing LP, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.